未登录 分享 收藏
分享 收藏
分享 收藏
Locus-specific human endogenous retroviruses reveal lymphoma subtypes 位点特异性人内源性逆转录病毒揭示淋巴瘤亚型 Singh, Bhavya; Dopkins, Nicholas; Fei, Tongyi; Marston, Jez L.; Michael, Stephanie; Reyes-Gopar, Helena; Curty, Gislaine; Heymann, Jonas J.; Chadburn, Amy; Martin, Peter; Leal, Fabio E.; Cesarman, Ethel; Nixon, Douglas F.; Bendall, Matthew L. 分享 收藏
Outcomes of Relapsed or Refractory Diffuse Large B-Cell Lymphoma Treated With R-GemOx: A Multicenter Cohort Study R-gemox治疗复发或难治性弥漫性大b细胞淋巴瘤的疗效: 一项多中心队列研究 Yamshon, S; Koff, JL; Larson, MC; Kahl, BS; Casulo, C; Lossos, IS; Haddadi, S; Stanchina, M; Chihara, D; Ayers, A; Habermann, TM; Wang, YC; Khurana, A; Nowakowski, GS; Reicks, TW; Farooq, U; Link, BK; Cohen, JB; Martin, P; Li, J; Shewade, A; Batlevi, CL; Lo-Rossi, A; Fox, D; Masaquel, A; Mun, Y; Cerhan, JR; Flowers, CR; Maurer, MJ; Nastoupil, LJ 分享 收藏
MRD-Driven Time-Limited Therapy of Acalabrutinib and Lenalidomide Plus Rituximab (ALR) or Obinutuzumab (ALO) in Patients with Treatment-Naive Mantle Cell Lymphoma: Phase 2 Trial Outcomes with MRD and cfDNA Analyses MRD驱动的有限疗程Acalabrutinib联合Lenalidomide和Rituximab（ALR）或Obinutuzumab（ALO）治疗初治套细胞淋巴瘤患者的疗效：含MRD和cfDNA分析的II期试验结果 Ruan, Jia; Bond, David A.; Shah, Bijal; Allan, John N.; Rutherford, Sarah C.; Gribbin, Caitlin; Chen, Zhengming; Hobbie, Brittany; Harbhajan, Melinda; Sahni, Tejasvi; Tam, Wayne; Bhinder, Bhavneet; Sigouros, Michael; Inghirami, Giorgio; Chen-Kiang, Selina; Elemento, Olivier; Maddocks, Kami J.; Leonard, John P.; Martin, Peter 分享 收藏
分享 收藏
Disrupting IL10 Signaling Overcomes Compound Copy Number Variation-Driven Clinical Resistance to CDK4/6 and BTK Inhibition in Mantle Cell Lymphoma 干扰IL10信号克服了复合拷贝数变异驱动的临床耐药性，对CDK4/6和BTK抑制在套细胞淋巴瘤中的作用 Di Liberto, Maurizio; Hu, Yang; Huang, Xiangao; Inghirami, Giorgio; Wang, Kevin; Lee, Christina Y.; Maddocks, Kami J.; Blum, Kristie A.; Ruan, Jia; Leonard, John P.; Bartlett, Nancy L.; Martin, Peter; Elemento, Olivier; Chen-Kiang, Selina 分享 收藏
分享 收藏
分享 收藏
分享 收藏
Impact of imaging frequency on progression-free survival in Alliance trials enrolling patients with follicular lymphoma Rutherford, Sarah C.; Yin, Jun; Pederson, Levi D.; Blum, Kristie A.; Martin, Peter; Jung, Sin -Ho; Grant, Barbara; Rosenbaum, Cara; Cheson, Bruce D.; Bartlett, Nancy L.; Mandrekar, Sumithra J.; Leonard, John P. 分享 收藏
分享 收藏
Integrative analysis of clinicopathological features defines novel prognostic models for mantle cell lymphoma in the immunochemotherapy era: a report from The North American Mantle Cell Lymphoma Consortium Vose, Julie M.; Fu, Kai; Wang, Lu; Mansoor, Adnan; Stewart, Douglas; Cheng, Hongxia; Smith, Lynette; Yuan, Ji; Qureishi, Hina Naushad; Link, Brian K.; Cessna, Melissa H.; Barr, Paul M.; Kahl, Brad S.; Mckinney, Matthew S.; Khan, Nadia; Advani, Ranjana H.; Martin, Peter; Goy, Andre H.; Phillips, Tycel J.; Mehta, Amitkumar; Kamdar, Manali; Crump, Michael; Pro, Barbara; Flowers, Christopher R.; Jacobson, Caron A.; Smith, Sonali M.; Stephens, Deborah M.; Bachanova, Veronika; Jin, Zhaohui; Wu, Shishou; Hernandez-Ilizaliturri, Francisco; Torka, Pallawi; Anampa-Guzman, Andrea; Kashef, Farshid; Li, Xing; Sharma, Sunandini; Greiner, Timothy C.; Armitage, James O.; Lunning, Matthew; Weisenburger, Dennis D.; Bociek, Robert G.; Iqbal, Javeed; Yu, Guohua; Bi, Chengfeng 分享 收藏
Matching-adjusted indirect comparison from the Lymphoma Epidemiology of Outcomes Consortium for Real World Evidence (LEO CReWE) study to a clinical trial of mosunetuzumab in relapsed or refractory follicular lymphoma 淋巴瘤流行病学结果真实世界证据联盟 (LEO CReWE) 研究的匹配校正间接比较与莫奈妥珠单抗治疗复发或难治性滤泡性淋巴瘤的临床试验 Maurer, Matthew J.; Casulo, Carla; Larson, Melissa C.; Habermann, Thomas M.; Lossos, Izidore S.; Wang, Yucai; Nastoupil, Loretta J.; Strouse, Christopher; Chihara, Dai; Martin, Peter; Cohen, Jonathon B.; Kahl, Brad S.; Burack, W. Richard; Koff, Jean L.; Mun, Yong; Masaquel, Anthony; Wu, Mei; Wei, Michael C.; Shewade, Ashwini; Li, Jia; Cerhan, James R.; Link, Brian K.; Flowers, Christopher R. 分享 收藏
Nine-year follow-up of lenalidomide plus rituximab as initial treatment for mantle cell lymphoma Yamshon, Samuel; Chen, Gui Zhen; Gribbin, Caitlin; Christos, Paul; Shah, Bijal; Schuster, Stephen J.; Smith, Sonali M.; Svoboda, Jakub; Furman, Richard R.; Leonard, John P.; Martin, Peter; Ruan, Jia 分享 收藏
The feasibility, acceptability, and usability of telehealth visits Gregory, Naina Sinha; Shukla, Alpana P. P.; Noel, Jahi J. J.; Alonso, Laura C. C.; Moxley, Jerad; Crawford, Andrew J. J.; Martin, Peter; Kumar, Sonal; Leonard, John P. P.; Czaja, Sara J. J. 分享 收藏
Evaluating the impact of eligibility criteria in first-line clinical trials for follicular lymphoma: a MER/LEO cohort analysis Luan, Danny; Fatola, Tolulope; Toure, Ahmed; Flowers, Christopher R.; Link, Brian; Friedberg, Jonathan W.; Cohen, Jonathon B.; Kahl, Brad; Lossos, Izidore S.; Nastoupil, Loretta; Maurer, Matthew J.; Cerhan, James R.; Martin, Peter 分享 收藏
Improving eligibility criteria for first-line trials for patients with DLBCL using a US-based Delphi-method survey Harkins, R. Andrew; Patel, Sharvil P.; Lee, Michelle J.; Switchenko, Jeffrey M.; Ansell, Stephen M.; Bartlett, Nancy L.; Blum, Kristie A.; Cashen, Amanda F.; Casulo, Carla; Friedberg, Jonathan W.; Johnston, Patrick B.; Kahl, Brad S.; Leonard, John P.; Link, Brian K.; Lossos, Izidore S.; Martin, Peter; Maurer, Matt J.; Mehta-Shah, Neha; Reagan, Patrick M.; Westin, Jason R.; Koff, Jean L.; Flowers, Christopher R. 分享 收藏
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
分享.png){kind=icon}
收藏.png)
BLOOD.png)
OAAI